GENFIT to acquire Versantis, expanding its liver disease portfolio
The late-stage biopharmaceutical company expects the deal to close in Q4 2022.
Source: mmm-online.com
Page 5 - Pascal Prigent News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pascal Prigent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pascal Prigent Today - Breaking & Trending Today
Ipsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global Partnership
PARIS--(BUSINESS WIRE)--Dec 17, 2021--
Source: cadillacnews.com
GENFIT: Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership
GENFIT: Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership ... | December 17, 2021
Source: marketscreener.com
Ipsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global Partnership
Agreement gives Ipsen global rights to develop and commercialize GENFIT's late-stage, first-in-class PPAR alpha and delta agonist elafibranor in Primary Biliary Cholangitis (PBC) Investigational
Source: finanznachrichten.de
January 13, 2021 Extraordinary Shareholders Meeting: Wide support for the resolutions submitted to the shareholders' vote but quorum not met on first convening Paris Stock Exchange:GNFT
January 13, 2021 Extraordinary Shareholders Meeting: Wide support for the resolutions submitted to the shareholders’ vote but quorum not met on first convening January 12, 2021 14:15 ET | Source: GENFIT S.A. GENFIT S.A. Loos, FRANCE French Partial buyback and amendment of the bond terms approved by approx. 98% of voting shareholders at this time Insufficient quorum of 20.63% on first convening, but greater than the 20% quorum required on second convening Extraordinary Shareholders Meeting will be reconvened on January 25, 2021 with the same agend...
Source: globenewswire.com